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Flow cytometry has shown to be a very useful tool in the assessment of plant-derived 
compounds, having potential anti-tumour activity. Our group has focused in the study of 
fractions and isolated compounds with biological activity over tumour cells and regulatory 
immune cells, such as dendritic cells. Also we have implemented a flow cytometry 
screening tests for estimating the biological activity of plant-derived fractions. 
The present chapter will discuss important and useful facts to be taken into account for 
effectively carrying out biological assays in this area. We will start with recommendations 
about the production of plant fractions and continue with the biological assessment of cell 
lines or monocyte-derived dendritic cells. Since these protocols are constantly evolving, 
herein we describe our current experience. 
2. Natural product specifications 
Natural product specifications will differ depending upon the type of plant material in 
which the study is to be undertaken: complex fractions or isolated compounds. Similarly, 
settings will differ depending upon the biological target assigned for the assay e.g. primary 
tumour cells, tumour cell lines, dendritic cells or antigen presenting cells. Our group has 
developed plant complex fractions enriched in secondary metabolites, using conventional 
organic solvent fractionation methods, and primary metabolites-enriched fractions using 
fractionation of aqueous solutions. Both types of fractions contain a vast variety of 
compounds, as well as structure diversity. 
Our group has been working with fractions enriched in secondary metabolites from Petiveria 
alliacea and Caesalpinia spinosa plants. The chemical complexity of the fractions is analysed by 
dereplication, by comparing the molecular weights of the compounds within the fraction 
with the molecular weights of compounds known to be present in the plant under study. 
Among the difficulties we have run into is the autofluorescence display by compounds  
www.intechopen.com
 
Clinical Flow Cytometry – Emerging Applications 
 
92 
present in our fractions, as well as in many other natural products, a condition that 
interferes with flow cytometry lectures. The autofluorescence displayed by many secondary 
metabolites, such as flavonoids, covers most of the visible spectrum overlapping the 
emission range of many flow cytometry fluorochromes. We have overcome such interference 
by making fraction dilutions and estimating fluorescence values at the overlapping 
wavelengths. Those values are used as background in the flow cytometry estimations. 
Another critical condition to be aware of is the fraction sterility condition with regard to cell 
culture contamination hazards. The presence of microorganisms in the plant material, such 
as viruses, bacteria or fungi, must be controlled. Chemical agents such as benzyl chloride, 
lauryl dimethyl ammonium (benzalkonium chloride) in concentrations between 50 and 100 
ppm could be used to prevent the microorganisms’ occurrence. Similarly, treatment with 
short wave ultraviolet radiation (UVC) within the range of 200-280 nm can reduce microbial 
load. In the case of stock solutions, membrane filtration (0.22 microns) is suggested, taking 
the precaution to previously check membrane solvent compatibility. The use of high-
pressure pasteurisation (600mPa, 20°C) has also been proposed to attain microorganism safe 
plant material. Chen et al, established that high-pressure pasteurisation for 2 to 5 minutes in 
Echinacea purpurea plant reduced microbial load without affecting biological activity. In 
addition, the presence of lipopolysaccharide (LPS) in plant-derived fractions must be 
avoided, since LPS is a major membrane component of gram-negative bacteria. LPS is 
recognised by macrophages and endothelial cells through CD14-TLR4 (toll like receptor) -
MD2 complex, triggering cytokine secretion and expression of co-stimulatory molecules. 
LPS may appear in the plant material from pathogenic bacteria (Pseudomonas, Xanthomonas, 
Burkholderia and Agrobacterium), or beneficial symbiotic Rhizobiaceae (Pseudomonas 
fluorescens). 
To estimate LPS presence in the fractions, a limulus amebocyte lysate (LAL) test is 
commonly used, although detection of 3β-hydroximiristate (a LPS component) can also be 
used. For LPS removal, an anti-endotoxin synthetic peptide -SAEP- cross-linked with 
polymyxin B (POLB), can be used to neutralise it. In relation to the fractions eluents, 
especially in non-polar fractions, it is advisable to use as first choice ethanol then secondly 
dimethyl sulfoxide (DMSO) for the stock solution preparation. Then proceed to dilute the 
fraction or isolated compound until the ethanol concentration in the cell culture does not 
exceed 0,02%.  
3. Instrument setup and colour compensation 
To ensure data analysis quality in multicolour flow cytometry, daily adjustments are 
necessary to acquire standard intensity peaks and build up adequate follow-up curves. 
Currently, there are several quality controls commercially available that can be used to 
monitor reagents’ performance, reproducibility, cell preparation and cell staining. Among 
the most commonly used are the beads of known concentration and a stable number of 
fluorochromes per bead (> 6-colour). Also they control parameters such as laser alignment, 
optics, fluidics, mean fluorescence intensity (MFI) (each bead in solution produces equal 
amounts of fluorescence), fluorescence signal coefficient variation, autofluorescence 
threshold and colour compensation. Standardisation of cytometer measurements is essential 
to accurately make comparisons between experiments. 
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On the other hand, biological samples (including normal peripheral blood) should be 
stained with the fluorochrome of interest to compensate the cytometer. The positive cell 
population must be set as the brightest signal for each fluorochrome. As a negative control, 
cells without antibody and marked with an irrelevant antibody or isotype control can be 
used. For tandem fluorochromes, it is important to compensate separately each reagent 
containing a tandem fluorochrome, because spectral emission properties can vary from lot 
to lot, between manufacturers and over time. Once the flow cytometer is adjusted and the 
immunophenotypic panels have been selected, it is essential to optimise and evaluate each 
reagent in terms of fluorescence intensity to exclude unwanted interactions between them. It 
is highly recommended to use normal peripheral blood as a sample control since positive 
and negative cell populations are needed to test the antibody under study. 
Using different fluorochromes at the same phenotypic panel can produce fluorescence 
spectral overlapping. In consequence the emitted light of one fluorochrome may appear in 
the other detector. To correct overlapping, a compensation protocol could be used. Herein, 
is the basic protocol that can be used for compensation adjustment using BD™ CompBeads 
set anti-mouse Igκ (binds mouse Kappa light chain-bearing immunoglobulin) and the BD™ 
CompBeads negative control (no binding capacity). Before starting the experiment it is 
necessary to prepare tubes with each conjugate antibody to compensate fluorescence. 
Briefly, pretitrated monoclonal antibody (MAb) amounts are added to stain buffer aliquots 
(e.g. phosphate-buffered saline, pH 7.6), the CompBeads anti-mouse Igκ and the 
CompBeads negative control. In this example: fluorocrome conjugated-fluorescein 
isothiocyanate (FITC)/phycoerythrin (PE)/peridinin chlorophyll protein-cyanin 5.5 
(PerCPCy5.5)/allophycocyanin (APC)/APCCy7- combinations of MAb are used. In 
addition, a tube containing the CompBeads negative control is used to adjust the 
photomultipliers voltage settings. After gentle mixing, the different bead aliquots are 
incubated for 30 min at room temperature (RT) under dark conditions. Then, the beads are 
washed with 2 mL of staining buffer/aliquot (10 min at 200 g). Immediately after the sample 
preparation is complete, data acquisition is performed on a FACS Canto II flow cytometer 
using the FACS DIVA software programme (BD Biosciences). For each MAbs combination 
with CompBeads, 5x103 events are acquired and stored. The flow cytometer compensation 
strategy employed is shown in Figures 1, 2 and 3. 
4. Cell lines selection  
Biological activity of plant complex fractions or isolated compounds is selective; their 
effect depends upon the nature of the cell line used at the assay. Our research interest has 
mostly been on compounds with activity on breast cancer cells, e.g. human breast 
adenocarcinoma (MCF7) from the American Type Culture Collection (ATCC, Rockville, 
MD) and mammary murine adenoma carcinoma (4T1), kindly donated by Dr. Alexander 
Asea, Texas A & M University. Similarly, we have used human melanoma cells (A375) 
kindly donated by La Universidad del Rosario (Bogotá, Colombia) and murine melanoma 
(Mel-Rel) donated by Armelle Prevost (Institute Curie, France). We have also used chronic 
myeloid leukaemia (HL60), human promyelocytic K562 cell lines from the ATCC and 
finally pancreatic cancer cells (Panc28 and L.3.6PL) donated by Dr. Steven Safe from Texas 
A & M University as biological agents. In addition we have some others cell lines, 
obtained from ATCC. 
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Fig. 1. Dot plot histograms for FACS Canto II cytometer compensation using the commercial 
BD™ CompBeads negative control (uncoupled with anti-mouse IgG) for voltage adjustment 
(parameters: Forward Scatter –FSC- and Side-Scatter-SSC- (panel A) and fluorescence 
detectors (FITC, PE, PERCPCY5.5, APC, APCCy7 and PECY7) (panels B-G). Histogram 
represents the negative value area for each parameter. The beads are gated on FSC and SSC 
(red dots in P1 region). Acquisition is done only in the P1 region verifying histograms for 
each fluorochrome and simultaneously adjusting the voltages for each fluorescent channel, 
so that the peak areas are located in the negative area (region P2 in each histogram). The 
adjusted minimum voltages in the photomultipliers are used for the BD™ CompBeads set 
anti-mouse Igκ and the BD™ CompBeads negative control acquisition mixture. Y axes units 
correspond to relative fluorescence intensity 
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Fig. 2. Dot plot histograms for FACS Canto II cytometer compensation using BD™ 
CompBeads set anti-mouse Igκ and the BD™ CompBeads negative control commercial 
mixture. After P1 region acquisition (containing the spheres mixture), histograms have two 
fluorescence emission peaks, a negative (no fluorescence emission) and a positive 
(fluorescence emission; P2 region) (panels A –F). The cytometer automatically discriminates 
positive and negative peaks and calculates the compensation for each and between 
fluorochromes. The compensation values are stored in the software for future experiments 
containing the same fluorochrome 
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Fig. 3. Optionally in a third step, instrument compensation could be checked by acquiring 
the bead mixture attached to each antibody conjugate and using the same compensation 
values calculated by the software as described in figure 2. Creating different two-dimensional 
dot plots with each fluorochrome on the x-axis and y-axis respectively and verifying that 
there is no fluorescence overlapping (panels B-I) (e. g. FITC vs PE, PE vs PercPC y 5.5, etc).  
If the fluorochrome signal is uncompensated, voltage manual adjustment is required 
Cells are cultured under humidified conditions with 5% CO2 in RPMI 1640 media, 
supplemented with 10% foetal bovine serum (FBS), 0.01 M Hepes, 100 µg/ml penicillin, 100 
U/ml streptomycin, 2 mM glutamine and 0.01 M of sodium pyruvate (Eurobio, France). It is 
important to determine if the fraction activity displays selectivity on highly proliferating 
cells, or to the contrary, if its activity can also affect normal cells. Lymphocytes derived from 
human peripheral blood, separated with Ficoll-Hypaque, or human gingival mucosa 
fibroblasts can be used as normal cell samples. 
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4.1 Mononuclear cell isolation by Ficoll-Hypaque gradient 
Mononuclear cells can be separated from heparin, EDTA, sodium citrate or defibrinated 
anti-coagulated blood. Equal parts of phosphate buffered saline (PBS) are used to dilute the 
blood sample at RT. In a 15 ml conical tube, 3 ml of ficoll are carefully placed and 4 ml of 
diluted blood are placed on top, avoiding damage to the gradient (the sample must be 
poured slowly along the tube walls). The tube is centrifuged (300 × g) for 30-40 minutes at 
RT. After centrifugation, four layers should appear in the tube. Granulocytes and 
erythrocytes are the cells found at the bottom of the tube, next is the ficoll hypaque layer, 
monocytes, lymphocytes and platelets are at the upper intermediate phase, and finally, at 
the top layer is the plasma. The layer containing the lymphocytes has to be carefully 
removed, transferred into a new tube, diluted with three parts of PBS (6 ml) and centrifuged 
(100 × g) for 10 min at RT. The latter washing procedure should be done twice and at the 
end cells must be suspended in supplemented culture medium. 
4.2 Gingival fibroblast generation  
Gingival fibroblasts are obtained from the gingival tissue of healthy volunteers. Briefly,  
a gingival sample is cut into small pieces and cultured in RPMI 1640 supplemented  
media with 10% FBS, 0.01 M Hepes, 100 µg/ml penicillin, 100 U/ml streptomycin, 2 mM 
glutamine and 0.01 M sodium pyruvate (Eurobio, France) under humidified conditions and 
5% CO2. The culture medium is replaced every three days until the fibroblasts are derived 
from the tissue. After two weeks of culture, a confluent fibroblast culture is obtained. 
5. Determination of fraction concentration and anti-tumour bioassays 
5.1 Fraction’s cytotoxic activity on tumour cells 
The fraction’s cytotoxic effect is evaluated by trypan blue and MTT assays (Sigma, St. Louis 
MO, USA) using tumour and normal cell cultures. Suspension or adherent tumour cells 
(5x103 cells/well or 3 x 103 cells/well, respectively) and fibroblasts (3 x 103 cells/well) are 
cultured in 96-well plates at different plant fraction concentrations (from 125 to 0.975 µg 
/ml) in ethanol (0.02% final concentration). Aqueous ethanol solution is used as a negative 
control and doxorubicin, etoposide, vincristine, taxol and camptothecin (10 µM) as positive 
controls, during 48 h at 37°C. Peripheral blood mononuclear cells (2 x 105 cells/well) are 
incubated for 12 h with phytohemagglutinin (Invitrogen Corp, Grand Island, NY, USA) 
before treatment. At the end of the incubation time, the culture media of the tumour and 
normal cells is removed and replaced with new RPMI 1640 media lacking phenol red dye 
(Eurobio, Toulouse, FR). 50 µl of MTT (1 mg/ml) [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide] (Sigma, St. Louis MO, USA), is placed in each well and incubated for  
4 h at 37°C. The formazan crystals are dissolved with DMSO and their optical density at  
540 nm is measured in a MultiskanMCC/340 (Labsystems, Thermo Fisher Scientific, 
Waltham, USA). Probit analysis is used to calculate the inhibitory concentration 50 (IC50) 
(MINITAB ® Release14.1 Statistical Software Minitab Inc. 2003). In addition, cell viability is 
determined using Newbauer haemocytometer and trypan blue dye. 
For these types of procedures the preparation of negative controls is extremely important. 
Since some plant fractions can reduce MTT reagent, a negative control containing plant 
fraction, culture media and MTT without cells, should be prepared.  
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5.2 Tumour cells’ mitochondrial membrane potential assessment 
For many years mitochondria was considered only as the cell energy source, generating 
ATP through oxidative phosphorylation and lipid oxidation. Now, is clear that this 
organelle has a pivotal role in apoptosis, a form of cell death characterised by morphological 
and biochemical specific changes. The mitochondrial membrane potential (∆Ψ), addresses 
the oxidative phosphorylation process and mitochondrial calcium uptake. If the electron 
transport ceases, as happens in ischemia, the inner mitochondrial membrane potential is 
developed at the expense of ATP hydrolysis. A decrease in ∆Ψ is often considered as an 
early apoptotic signal, an event that can be detected by flow cytometry. Nonetheless, the 
relationship between the mitochondrial membrane depolarisation and apoptosis is still 
controversial Some researchers even consider a decrease in ∆Ψ an irreversible sign of 
apoptosis, while others say it is an apoptotic late event. 
Changes in mitochondrial membrane potential can be assessed using a lipophilic cationic 
probe JC-1 (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide). The 
probe potential depends on its mitochondrial accumulation, which is indicated by a change 
in green fluorescence (525nm) to red (590 nm) emission. The mitochondrial membrane 
depolarisation is indicated by a decrease in fluorescence intensity through the red/green 
ratio. The change in colour is due to the “red fluorescent J aggregates” accumulation which 
in turn depends on the concentration. One advantage of JC-1 dye is the possibility to be 
used in a wide variety of cell types, including myocytes, neurons and tumour cells, among 
others. 
For optimal results tumour cell concentration in the culture should be one in which 
confluence is reached only after incubation for 48 hours. Usually, 2.5 x 105 cells/well are 
placed in 12-well plates. Adherent cells should be allowed to adhere before the treatment 
begins. Cells are tested with different plant fraction concentrations, using ethanol aqueous 
solution as a negative control and valinomycin as a positive inductor of membrane  
 
Fig. 4. C. spinosa-derived fraction induces mitochondrial membrane depolarisation. K562 
cells treated with the fraction or the negative control. The left panel shows the eluent effect 
(ethanol), the right panel shows the fraction effect on the cell mitochondrial membrane 
depolarisation 
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depolarisation. The assay is carried out in kinetics of 4, 8, 12, 24 and/or 48 h. At the end of 
the treatment, cells are collected in cytometry tubes and JC-1 dye (2.5 mg/ml in PBS) is 
added for 10 minutes at 37°C. JC-1 fluorescence intensity is quantified in a flow cytometer 
FACSDiVa (Becton Dickinson, New Jersey, USA) and data analysis is performed using 
FlowJo software (Tree Star Inc., Ashland, USA). All treatments are done in triplicate and 
results are expressed as mean +/- SEM. Figure 4. 
5.3 Analysis of apoptosis vs necrosis - annexin V/PI staining 
There are two main cell death mechanisms: apoptosis or programmed cell death and 
necrosis or trauma cell death. Both types of cell death have different morphological and 
biochemical characteristics. Changes as phosphatidylserine (PS) externalisation, chromatin 
and nuclear condensation, appearance of apoptotic bodies, among others, can be seen in 
apoptotic cells. Necrotic cells show nuclear swelling, chromatin flocculation, loss of nuclear 
basophilia, breakdown of the cytoplasmic structure, organelle function and swelling 
cytolysis. 
Plasma membrane phospholipids display asymmetrical distribution. Most of the 
phosphatidylcholine and sphingomyelin are mainly located at the outer side, while PS is 
mostly located at the inner side of the plasma membrane. During apoptotic cell death, 
phospholipid asymmetry is disturbed and PS begins to expose at the membrane outer side. 
Annexin V is an anticoagulant protein with the property of binding PS with high affinity; in 
conjugation with fluorochromes it is used to detect apoptotic cells by flow cytometry. Since 
apoptotic cells begin to react with annexin V before the plasma membrane loses the ability 
to exclude cationic dyes as propidium iodide (PI), marking the cells with a combination of 
annexin V-FITC/PI, allows us to distinguish four populations: non-apoptotic cells (annexin 
V-FITC negative/PI negative), early apoptotic cells (annexin V-FITC positive/PI negative), 
late apoptotic cells (annexin V-FITC positive/PI positive) and necrotic cells (annexin V-FITC 
negative/PI positive). 















Fig. 5. 4T1 cells marked with annexin V and PI after treatment with C. spinosa fraction. 
Ethanol solution is used as a negative control and doxorubicin as a positive control 
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Tumour cells (3 x 105) are treated with plant fractions at different concentrations, or 
doxorubicin (positive control) or ethanol solutions (negative control), for 24 or 48 h. After 
the treatment, cells are suspended in an annexin V buffer (Hepes 100 mM, NaCl 140 mM, 
CaCl2 2.5mM), incubated with annexin V-Alexa fluor 488 for 8 min at 37°C and then 
incubated with IP for 2 min at 37°C. Assays are made in triplicate. Cells are acquired in a 
FACSAria I (Becton Dickinson, New Jersey, USA) and FlowJo (Tree Star Inc, Ashland, USA) 
software for analysis (Figure 5). 
5.4 Cell cycle analysis 
Cell division is an evolutionarily conserved process involving series of molecular events. 
The mammalian cell cycle has five phases: three gaps, a G0 phase where the quiescent or 
resting cells are; G1 and G2 phases were RNA and protein synthesis takes place, the S phase 
is where DNA replicates and the M phase is where mitosis and cytokinesis happens. G0, G1, 
S and G2 are collectively known as interphase. Cell cycle control is a fundamental cell 
process. The progression from G1 to S to G2 and mitosis is coordinated at checkpoints. 
Before mitosis begins, the cell must check if the DNA is fully replicated and free of damage. 
The spindle mitotic control stops the cell cycle if the spindle is not properly formed or if the 
chromosomes are not properly attached. DNA aneuploidy or mutations are the result if the 
cell avoids these controls. A gap in any of the control sites allows the cell to repair DNA and 
enter mitosis, otherwise it goes into apoptosis. In cancer, the control repair of the cell cycle is 
damaged and this is precisely where new drugs based on natural products or their 
derivatives can achieve a stop in tumour cell division and perhaps induced apoptosis.  
 
Fig. 6. Effect of a P alliacea-derived fraction on cell cycle distribution. A375 cells treated with 
plant fractions during 12, 18, 24 and 48 h. Ethanol is used as a negative control and 
vincristine as a positive control 
A common and simple way to evaluate cell cycle phases is to measure the DNA cell content. 
DNA cell content allows the discrimination between cell populations in G0/G1, S and 
G2/M cell cycle phases. The DNA can be labelled with fluorescent dyes and cell 
fluorescence can be measured by flow cytometry. Dyes such as PI, Hoechst, 7-AAD and 
DAPI can be used for this purpose. To start, cells must be synchronised in the G1 phase, a  
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process that can be done by depriving the cells of serum. Mel Rel, A375 and K562 cells are 
deprived of FBS for 72 h are seeded in 12-well plate (4x105 cells/well) and treated with 
different plant fraction concentrations or vincristine (positive control) or ethanol (negative 
control) for 12, 18, 24 and 48 h under humidified conditions 37°C and 5% CO2. Next cells are 
washed and fixed with ethanol (70% ice-cold) for 18 h, then suspended in PBS 1X with 
100 U/ml RNAse A, 50 μg/ml PI (Sigma, St Louise, MO, USA) at RT for 30 min. DNA cell 
content is measured by flow cytometry using a FACSAria I (Becton Dickinson, New Jersey, 
USA). The cell cycle distribution percentages are calculated by FlowJo (Tree Star Inc., 
Ashland, USA) and ModFit LT software. Treatments are done in triplicate (Figure 6). 
6. Immunomodulatory evaluation on human-derived dendritic cells 
Natural products are good immunostimulating agents and can be evaluated using human 
monocyte-derived dendritic cells. Although the model cannot be used as a screening test, 
once standardised, it allows a large number of compounds to be tested in a more 
physiological way. The test measures the plant fractions real activity on normal human cells. 
Following we will describe the procedures carried out in our laboratory which includes 
dendritic cell separation and flow cytometry measurements of the biological activity of 
plant-derived fractions.  
6.1 Monocyte-derived dendritic cell differentiation   
Peripheral blood monocytes are attained from concentrated packs (15 ml) of leukocytes from 
healthy volunteers attending the blood bank and who previously gave informed consent. 
The mononuclear cells are separated from the peripheral blood using the Ficoll Hypaque 
density gradient (Amercham, GE Healthcare Europe GmbH). CD14+ population cells are 
separated with a MiniMACS positive selection kit, using the protocol suggested by the 
manufacturer, without any modifications (Miltenyi Biotech GmbH, Bergisch, Gladbach, 
United Kingdom). Cell purity is determined by flow cytometry. Eluted cells (10 µl) are 
labelled with anti-CD14-APC (Pharmingen, San Diego, CA, USA). Monocytes with purity 
over 98% are grown for five days in 24-well plates in RPMI 1640 (1 ml) supplemented with 
5% FBS, 2 mM glutamine and 100 IU/ml penicillin/streptomycin (Eurobio, Paris, France). 
The differentiation stimulus used is 800 UI/ml of Granulocyte-Macrophage colony-
stimulating factor and 1000 IU/ml of interleukin 4 (R & D Systems, Minneapolis, MN, USA). 
After three days of differentiation, one half of the media culture is replaced with fresh 
medium and supplemented with half of the stated cytokines concentration.  
At day five, monocyte-derived dendritic cells (MDDC) are stimulated with different 
concentrations of the plant fractions dissolved in ethanol, DMSO or culture medium, 
depending upon the fraction solubility, for 48 h. Control DCs (immature) are incubated 
without stimulus or with the plant fractions eluents. As maturation control, DCs are 
stimulated with LPS 1µg/ml in PBS (Sigma, St Louis, MO, USA). Additionally, plant 
fractions are pre-treated with agarose beads coated with POLB (Sigma, St Louis, MO, USA) 
to eliminate possible LPS contamination. To discard LPS presence in the plant fractions, all 
reagents are tested with LAL (Bio Whittaker Inc., Walkersville, MD, USA) and used 
according to manufacturer's instructions. Cell viability is estimated to monitor the fractions’ 
or compounds’ potential toxicity using the trypan blue exclusion test. 
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6.2 Dendritic cell phenotype analysis 
Expression of membrane surface markers in immature DCs or those treated with LPS, or 
with compounds or fractions, are assessed after seven days. Phenotypic analysis is 
performed using anti-CD1a Pacific Blue, anti-CD86 PE, anti-CD83 FITC, anti-HLA-DR APC-
H7, anti-CD209 PerCP-Cy5 and anti-CD206 APC (BD Biosciences). The cells are suspended 
in a PBS buffer (0.1% sodium azide and 2% FBS) at 4°C. To discriminate living from dead, 
cells are marked with LIVE/DEAD®Fixable Aqua Dead Cell Stain (Invitrogen. Carlsbad, 
CA. USA). Also 5 to 20 μl of each antibody is added according to the manufacturer's 
instructions and incubated for 30 min at RT. After incubation, cells are washed twice with 
buffer and suspended in 400 μl, to be read on the FACSAria. The analysis is carried out with 
FACSDiva ™ 6.1(BD Immunocytometry Systems, BD Biosciences, Franklin Lakes, NJ, USA) 
and FlowJo 8.7 (Tree Star Inc., Ashland, USA). As an example, Figure 7 shows how a 
galactomannan derived from the C.spinosa plant, induces maturation of human dendritic 




Fig. 7. Galactomannan induces phenotypic and functional maturation of DCs. DC cultured 
for 48 h with LPS (1 μg/mL) and galactomannan (7 and 21 μg/mL). An increase in expression 
of membrane surface molecules such as HLA-DR, CD86 and CD83 is shown after treatment 
with galactomannan (black) as compared to the controls (grey). Histograms represent one of 
four independent experiments. Differences on the mean fluorescence are shown on the table 
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6.3 Phagocytosis assays 
To examine DC’s phagocytic capacity, 100,000 DCs/well are grown in RPMI medium 
supplemented with 5% FBS and stimulated for 48 h with the different treatments. Immature 
and stimulated DCs are washed with Hanks buffer and suspended in 100 μl (0.5 μg/ml) of 
E. coli pHrodo™ (Invitrogen) bioparticles, for 3 h at 37°C. Bio-particles fluorescence is read 
in a fluorometer using an excitation filter of 535 nm and an emission filter of 595 nm (Dynex 
Technologies, Chantilly, VA, USA). The phagocytic cell percentage is estimated by flow 
cytometry. DCs are labelled with anti-CD11c-APC and the double labelled cell population is 
analysed. Assays are performed in triplicate and the analysed as previously described. 
Figure 8 illustrates the phagocytic activity induced by a galactomannan derived from  
C. spinosa. 
 
Fig. 8. Phagocytosis is evaluated by staining DCs (MDDC) with CD11c-APC antibody. The 
scatter plots show the cells after the treatments. DCs (MDDC), DCs (MDDC) plus LPS, DCs 
with galactomanan (GLM) 63, 21 and 7 (μg mL -1). Dot plots are representing one of four 
independent experiments 
6.4 Mixed leukocyte reaction 
Immunostimulatory activity of natural products can be evaluated by measuring the DCs’ 
ability to induce allogeneic response in an assay named mixed leukocyte reaction. Human 
monocyte-derived DCs are stimulated for 48 h with LPS (1µg/ml) or plant-derived fractions 
at different concentrations in RPMI supplemented medium. The stimulated DCs are 
recovered, washed and cultured in fresh RPMI medium supplemented with 5% of human 
AB serum GemCell™ (Gemini Bio-Products, West Sacramento, CA). 500,000 CDs/well  
are cultured at different ratios of allogeneic peripheral blood mononuclear cells (PBMC)  
(1:2, 1:5 and 1:10) previously obtained through Ficoll Hypaque gradient and labelled with  
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2.5 µM of carboxyfluorescein succinimidylester (CFSE) according to the manufacturer's 
recommendations (Invitrogen). Cells are collected after five days of co-culture; the first cells 
are marked with fluorescent viability marker aqua reactive dye (Invitrogen) and the second 
with anti-CD3 PerCP, anti-CD4 APC-H7 and anti-CD8 Pacific Blue (BD Biosciences). 
Samples are acquired on a FACSAria (BD Biosciences) and analysed as described above. As 
an example, Figure 9 shows T cell proliferation after treating DCs with a galactomannan 
derived from C. spinosa. 
 
Fig. 9. (A) Dendritic cells (MDDCs) induce allogenic CD4 and CD8 T cell proliferation after 
treatment with a galactomannan derived from C. spinosa. Antigen presenting DCs (MDDC) 
after stimulation with LPS (1μg mL -1) or GLM (7 or 21 μg mL -1) determined by T cell 
proliferation assays. PBMCs stained with CFSE (2,5 μM) and co-cultured with DCs (MDDC) 
in ratios 1:2, 1:5 and 1:10 (DCs: PBMC) over five days. CD4+ and CD8+ (B) cell proliferation 
is determined by specific antibodies and analysed through flow cytometry. Dot plots are 
representing one of four independent experiments  
6.5 Cytokine secretion measurement  
Cytokine secretion can be assessed by flow cytometry after stimulating with sterile and  
LPS-free plant fractions or compounds for 48 h as indicated above. The CBA kit (human 
inflammation cytometric bead array kit) (BD Biosciences) is used to evaluate levels of 
proinflammatory cytokines such as IL-1, IL-6, IL-8, IL-10, IL-12p70, and TNF-α, in the 
culture supernatant according to the manufacturer's instructions (CBA, BD Biosciences). The 
CBA application allows flow cytometry users to quantify simultaneously multiple proteins 
based on the cytometer capability to detect fine levels of fluorescence. The beads are coupled 
to antibodies that can capture different substances. Each bead has a unique fluorescence 
intensity allowing them to mix and record all bead signals at the same time and in a single 
tube. The analysed supernatants are obtained from 1x106 cells/per well and can be stored at 
-80°C until analysis. Marking is done according to the supplier instructions and the tubes 
are analysed as described above. 
A. 
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In general terms, flow cytometry constitutes a powerful tool to evaluate the anti-tumour and 
immunomodulatory activities of natural products, always keeping in mind the correct use of 
the controls and the instrument settings. 
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